市场调查报告书
商品编码
1496764
大麻市场:按形式、产品类型、化合物、来源、分销管道、应用 - 2024-2030 年全球预测Cannabis Market by Form (Concentrated Oil, Cream, Food Additive), Product Type (Concentrates, Flower, leaves), Compound, Source, Distribution Channel, Application - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年大麻市场规模为327.3亿美元,预计2024年将达417.7亿美元,2030年将达到1872.4亿美元,复合年增长率为28.29%。
源自大麻的大麻市场产品包括但不限于干燥花、浓缩物、食用品、外用药和大麻素,例如 THC(四氢大麻酚)和 CBD(大麻二酚)。大麻产业服务于各种最终用途领域,包括医疗、製药、个人护理以及食品和饮料。在医疗领域,大麻用于缓解与慢性疼痛、癌症、癫痫、多发性硬化症等相关的症状。大麻的休閒用途提供了酒精和烟草等传统休閒产品的替代品。大麻市场范围包括全球和区域销售、产品创新、供应链管理、监管状况等。大麻市场成长的主要驱动力是日益合法化、扩大药用用途以及越来越多地采用大麻作为消费品。此外,遗传学和种植技术的进步以及大麻相关调查投资的增加也有助于市场扩张。大麻市场的最新潜在机会包括快速成长的 CBD 市场,特别是在健康和保健领域,整合区块链以提高供应链透明度,以及探索新的输送系统以提高生物有效性。饮料和偏好产品等大麻产品以及根据个人基因特征量身定制的个人化大麻药物领域的创新尤其活跃。此外,为了吸引具有环保意识的消费者,我们将引入环保的种植和加工方法,克服耻辱,并投资于消费者教育以告知负责任的使用。利用人工智慧和机器学习对种植和消费者偏好进行预测分析预计将推动市场成长。然而,不同司法管辖区存在复杂的监管障碍、高昂的合规成本以及大麻使用持续存在的污名化。此外,剂量和摄取方法缺乏标准化、黑市经营者的激烈竞争以及银行和金融服务的高障碍限制了市场潜力。
主要市场统计 | |
---|---|
基准年[2023] | 327.3亿美元 |
预测年份 [2024] | 417.7亿美元 |
预测年份 [2030] | 1872.4亿美元 |
复合年增长率(%) | 28.29% |
区域洞察
美洲是一个复杂且快速扩张的大麻市场,各州之间的法律体制存在细微差异,联邦层级几乎没有变化。消费者的需求因地区和人口而异,趋势显示对药用大麻产品和合法州休閒大麻产品的需求显着增加。顾客的购买行为显示出对偏好和电子烟的强烈趋势。虽然新专利的竞争加剧,特别是在种植技术和大麻素合成方面,但一些州已经开始了调查计画。在亚太地区,中国和印度涉足大麻市场主要集中于生产大麻,这是一种非精神活性品种。中国是大麻衍生产品(包括纺织品和大麻二酚(CBD)萃取物)的最大生产国之一,但国内消费受到严格监管。另一方面,印度是一个有着古老文化联繫的新兴市场,但仍受到严格监管,并显示出在医学研究和阿育吠陀方面的应用潜力。在欧洲,大麻的监管环境分散,德国、义大利和荷兰等国家在患者准入和产品多样性方面处于领先地位,并且总体上正在走向更加开放的医药市场。欧盟客户的购买行为反映出人们对大麻潜在医疗益处的认识和接受程度不断提高,从而导致对药用大麻产品和相关研究的投资增加。
FPNV定位矩阵
FPNV 定位矩阵对于评估供应商在大麻市场的定位至关重要。此矩阵提供了对供应商的全面评估,并检查与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果,供应商被分为代表其成功程度的四个像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对大麻市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献,您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外,该分析也为此细分市场的竞争性质提供了宝贵的见解,包括研究的累积时间、片段化主导地位和合併特征等因素。有了这些详细信息,供应商可以做出更明智的决策并製定有效的策略,以在市场竞争中保持领先地位。
策略分析与建议
策略分析对于寻求在全球市场站稳脚跟的组织至关重要。透过彻底评估其当前在大麻市场的地位,公司可以做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析,以确定核心优势和需要改进的领域。
[187 Pages Report] The Cannabis Market size was estimated at USD 32.73 billion in 2023 and expected to reach USD 41.77 billion in 2024, at a CAGR 28.29% to reach USD 187.24 billion by 2030.
The cannabis market products derived from cannabis include but are not limited to dry flowers, concentrates, edibles, topicals, and cannabinoids such as THC (tetrahydrocannabinol) and CBD (cannabidiol). The cannabis industry serves various end-use sectors, such as healthcare, pharmaceuticals, personal care, and food & beverages. In the medical sector, cannabis is prescribed to alleviate symptoms associated with chronic pain, cancer, epilepsy, and multiple sclerosis, among others. The recreational use of cannabis provides an alternative to traditional leisure substances such as alcohol and tobacco. The scope of the cannabis market includes global and regional sales, product innovation, supply chain management, and regulatory landscapes. Cannabis market growth is predominantly driven by increasing legalization, growing medicinal applications, and the rising adoption of cannabis as a consumer good. Furthermore, advancements in genetics and cultivation technology, and increasing investment in cannabis-related research, contribute to the market's expansion. The latest potential opportunities within the cannabis market include the burgeoning CBD market, especially in the health and wellness sector, the integration of blockchain for supply chain transparency, and the exploration of new delivery systems to enhance bioavailability. Innovations are particularly thriving in areas of cannabis-infused products, such as beverages and edibles, as well as personalized cannabis medicines tailored to individual genetic profiles. Furthermore, implementing eco-friendly cultivation and processing methods to appeal to environmentally-conscious consumers and investing in consumer education to overcome stigma and inform about responsible use. Leveraging AI and machine learning for predictive analytics in cultivation and consumer preferences is expected to propel market growth. However, complex regulatory hurdles across different jurisdictions, high compliance costs, and the persistent stigmatization of cannabis use. In addition, the lack of standardized dosing and methods of consumption, significant competition from black-market operators, and hurdles in banking and financial services pose limitations to the market's potential.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 32.73 billion |
Estimated Year [2024] | USD 41.77 billion |
Forecast Year [2030] | USD 187.24 billion |
CAGR (%) | 28.29% |
Regional Insights
The Americas represents a complex and rapidly expanding cannabis market, differing minimally at the federal level but with nuanced legal frameworks across the states. Consumer needs vary significantly by region and demographics, with trends showing a substantial increase in demand for both medicinal and, in legal states, recreational cannabis products. Customer purchasing behavior demonstrates a strong inclination towards edibles and vapes. Several states have initiated research programs while the race for new patents is intense, particularly in cultivation tech and cannabinoid synthesis. In APAC, China's and India's involvement in the cannabis market is predominantly focused on the production of hemp, a non-psychoactive variety of cannabis. China is one of the largest producers of hemp-derived products such as textiles and cannabidiol (CBD) extracts, though consumption within the country remains strictly controlled. Meanwhile, India presents a nascent market with ancient cultural ties to cannabis, and while still heavily regulated, it shows potential for medical cannabis research and Ayurvedic applications. In Europe, the regulatory landscape for cannabis is fragmented but generally moving towards more open medicinal markets, with countries such as Germany, Italy, and the Netherlands leading in patient access and product diversity. The EU's customer purchasing behavior reflects a growing awareness and acceptance of the potential medical benefits of cannabis, leading to increased investment in pharmaceutical cannabis products and related research.
Market Insights
The market dynamics represent an ever-changing landscape of the Cannabis Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Cannabis Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Cannabis Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Organigram Announces USD 92.91 Million Investment from BAT and Creation of "Jupiter" Strategic Investment Pool
Organigram Holdings Inc. announced a significant USD 92.91 million equity investment from BT DE Investments Inc., a subsidiary of British American Tobacco. This strategic infusion of capital represents a powerful endorsement from a leading consumer goods company and is poised to fast-track Organigram's growth trajectory. With the investment, named "Jupiter," Organigram aims to expand its reach, enhance its technological capabilities, and diversify its product offerings. The initiative further cements the already robust partnership with BAT, tapping into their expansive global resources and scientific prowess for shared progressive ventures. [Published On: 2023-11-06]
Tilray Closes Acquisition of Hexo Corp To Create 'Largest Canadian Cannabis Company by Revenue'
Tilray, Inc. has effectively concluded its acquisition of Hexo Corp, solidifying its position as the preeminent Canadian cannabis company based on revenue. This strategic move bolsters the firm's competitiveness against Canopy Growth Corporation, positioning it for market leadership. Additionally, the integration is set to drive significant operational efficiencies, with anticipated annual cost savings of USD 27 million. In the mechanics of the deal, Tilray issued approximately 19.5 million common shares, granting former Hexo shareholders 0.4352 of a Tilray share for each Hexo share held, leading to the cessation of Hexo's stock trading. [Published On: 2023-06-26]
Curaleaf Completes Acquisition of Deseret Wellness
Curaleaf Holdings, Inc. has successfully finalized its acquisition of Deseret Wellness, Utah's foremost cannabis retailer. This strategic move significantly bolsters Curaleaf's presence in the burgeoning Utah market, expanding their local dispensary count to four and extending the company's reach to an impressive 150 retail locations throughout the United States. The integration of Deseret Wellness under the Curaleaf banner marks yet another milestone in the company's expansion, highlighting its commitment to growth and leadership in the nation's competitive cannabis industry. [Published On: 2023-04-10]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Cannabis Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Cannabis Market, highlighting leading vendors and their innovative profiles. These include Acreage Holdings, Aphria, Inc., Aurora Cannabis Inc., Cannabis Science Inc., Canopy Growth Corporation, Chronos Group Inc., Cresco Labs, Inc., Curaleaf Holdings, Inc., CV Sciences Inc., EcoGen Biosciences, Elixinol Wellness Limited, Extractas Bioscience, Folium Europe B.V., Green Thumb Industries Inc., Lexaria Bioscience Corp., Medical Marijuana, Inc., MediPharm Labs Inc., Organigram Holdings Inc., Peace Naturals Project Inc., PharmaHemp d.o.o., StenoCare A/S, The Seed Cellar, and Tikun Olam.
Market Segmentation & Coverage
TABLE 3